Once Monthly C.E.R.A. Found Beneficial

October 19 2007

BARCELONA—Once-monthly dosing of continuous erythropoietin receptor activator (C.E.R.A.) maintains stable hemoglobin levels in CKD patients regardless of age, gender, or comorbidities, according to study data presented here at the 44th Congress of the European Renal Association-European Dialysis and Transplant Association.

<< Return to Once Monthly C.E.R.A. Found Beneficial

Your Email Address:

Recipient(s) Email Address:

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Include a message (optional):

The e-mail address(es) that you supply to use this service will only be used to send the requested article.